Indore Online Journal

eClinical Solutions Market Worth $15.7 Billion By 2027 | CAGR: 13.8% | Grand View Research, Inc.

 Breaking News
  • No posts were found

eClinical Solutions Market Worth $15.7 Billion By 2027 | CAGR: 13.8% | Grand View Research, Inc.

August 21
21:49 2020
eClinical Solutions Market Worth $15.7 Billion By 2027 | CAGR: 13.8% | Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to a new report by Grand View Research, Inc., The global eClinical solutions market size was estimated at USD 5.6 billion in 2019 and is expected to exhibit a CAGR of 13.8% over the forecast period. Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth.

As per the report by Grand View Research Inc., the global eClinical Solutions Market, estimated to value at USD 15.7 billion by 2027. It is expected to witness a 13.8% CAGR in the period of forecast. The usage of software solutions in clinical trials, rising R&D actions by Pharmaceutical and Bio Pharma companies, plus increasing support of the customers, these are the factors expected to power the demand for eClinical Solutions.

The technical progressions, for example Wi-Fi connectivity plus the capturing of electronic data, are expected to impel the development of the market for eClinical Solutions, in the near future.  The clinical data increases owing to the need for evaluation of clinical diagnosis that boosts the efficiency of clinical solutions. Unmet requirements, to administer the well organized procedure of clinical development, are in position to increase the market for eClinical solutions, in the period of forecast.

Inclination for data centric method and digital revolution, in the area of clinical trials, are also offering remarkable thrust to the development of the market for eClinical solutions. Owing to the huge quantity of data generated at some stages in the process of clinical development, demand for incorporated clinical IT solutions is growing. The eClinical solutions present a solo source of information, which assists to optimize the charges by way of abolishing the entry of superfluous data and dropping on site conformation, along with the authentication of source data. Growing alertness, about these compensations, is expected to boost the market for eClinical solutions.

Download Free Sample Report @

Implementation of eClinical course of work in the testing, proposes a huge prospective in the development of the clinical processes. These solutions are capable to assist in making decisions at each phase of the process. Similarly, they assist in decreasing the time and the cost between the stages of development, by way of using faultless designs plus recognizing the faulty compound. Additionally, it provides speedy contact with the records and the information regarding the safety of the patients. This is supportive in making fast decisions.

Effect of Covid-19:
The outbreak of Covid-19 has affected the global market. Several companies operating in the field of eClinical solutions are enforced to stop their process of development and manufacturing due to the Covid-19 virus. The governments have revised their trade policies hence the functioning of several markets remains partially suspended all over. This interruption in the actions of business process is openly affecting the flow of revenue.

Further findings from the report suggest:

  • Based on the end use, CROs detained the biggest share of the market, in 2019. Due to the increasing preference of pharmaceutical companies to decrease the general overheads, the division is estimated to develop by a significant speed, throughout the period of forecast.
  • Due to the benefits, for example continuous centralized administration of clinical trial actions, riddance of dependence on labor intensive procedure, concurrent tracking of status, and upholding of numerous records, which collectively upgrade the general effectiveness of clinical trials, based on products, CTMS headed the market for eClinical solutions, in 2019.
  • By means of the method of delivery, due to the various incorporated features for example simple way of backing up of data, insignificant cost of handling, flexibility, greater convenience, and cloud centered systems, are expected to show the maximum CAGR, throughout the period of forecast. Instantaneous information is available over these systems. This facilitates the users to take fast decisions and offer professional information for risk centered monitoring.
  • Nearly all companies have undertaken a variety of business policies for example development of new products, and mergers & acquisitions, which increases their share in the market.

Have some specific queries about this report, our team of analyst will be glad to help!

Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the market over the forecast period.

Some of the important companies for eClinical Solutions Market are:
·         ERT
·         CRF Health
·         Bio Clinica
·         Medi data Solutions, Inc.
·         DATATRAK International, Inc.
·         Omni Comm. Systems, Inc.
·         PAREXEL International Corporation
·         Oracle Corporation
·         IBM Watson Health

Moreover, digital transformation in the field of clinical trials and preference for data centric approach are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.

Adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision making in every stage of the development process. They also help reduce cost and time between development phases by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which is helpful in making quick decisions.

Check out special pricing options for sectional purchase and startup companies

The global market has been segmented on the basis of end-use into academic institutes, medical device manufacturers, hospitals, CROs, and pharmaceutical and biotechnology companies. CROs held the largest share in the market in 2019. The segment is projected to expand at a remarkable CAGR during the forecast period owing to growing inclination of pharmaceutical companies to reduce overall expenditure. Rising usage of eClinical solutions in research is further widening the scope of the segment. Benefits of outsourcing clinical trials to CROs include cost advantages, increased efficiency of services, enhanced productivity, and higher focus on core areas of development critical to a company’s growth.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States